Anesthesia Instructional Videos

Watch the videos below to gain a deeper understanding of anesthesia products from Abbott Animal Health:

SevoFlo^® (sevoflurane)

SevoFlo (sevoflurane) is indicated for induction and maintenance of general anesthesia in dogs.

Instructional Videos

• SevoFlo at your practice
• Filling the vaporizer
• Using SevoFlo with a facemask 
• Using SevoFlo with PropoFlo™ (propofol) or PropoFlo™ 28 (propofol)

SevoFlo Safety Information

Most Common Adverse Reactions:

The most frequently reported adverse reactions during maintenance anesthesia were hypotension, followed by tachypnea, muscle tenseness, excitation, apnea, muscle fasciculations and emesis.

Contraindications:

SevoFlo (sevoflurane) is contraindicated in dogs with a known sensitivity to SevoFlo (sevoflurane) or other halogenated agents.

Warnings:

• Like other inhalation anesthetics, SevoFlo (sevoflurane) is a profound respiratory depressant.
• Respiration must be monitored closely in the dog and supported when necessary with supplemental oxygen and/or assisted ventilation.
• Due to SevoFlo's (sevoflurane) low solubility in blood, increasing the concentration may result in rapid hemodynamic changes compared to other volatile anesthetics.
• Potassium hydroxide containing CO2 absorbents (e.g., BARALYME^®) are not recommended for use with sevoflurane.

See package insert for full prescribing information, adverse reactions and precautionary statements.

PropoFlo^™ (propofol) and PropoFlo™ 28 (propofol)

PropoFlo (propofol) and PropoFlo™ 28 (propofol) is a versatile anesthetic injection indicated for use in dogs for induction and maintenance of general anesthesia for up to 20 minutes and for induction where maintenance is provided by inhalant anesthetics.

Instructional Videos

• PropoFlo and PropoFlo 28 at your practice
• Product Overview
• Induction
• Managing Apnea
• Maintenance
• Recovery
  

  

  

  

PropoFlo Safety Information

Overdosage:

Rapid administration or accidental overdosage of PropoFlo (propofol) may cause cardiopulmonary depression. Respiratory arrest (apnea) may be observed.

Precautions:

PropoFlo (propofol) contains no antimicrobial preservatives. Strict aseptic techniques must always be maintained during handling since the vehicle is capable of supporting the rapid growth of microorganisms.

Warnings:

Rapid single or repeat bolus administration may cause undesirable cardiorespiratory depression including hypotension, apnea and oxygen desaturation. When using PropoFlo (propofol), patients should be continuously monitored and facilities for the maintenance of a patent airway, artificial ventilation and oxygen supplementation must be immediately available.

Side Effects:

The primary side effect of PropoFlo (propofol) is respiratory depression as evidenced by tachypnea and apnea.

Contraindications:

PropoFlo (propofol) injection is contraindicated in dogs with a known hypersensitivity to PropoFlo (propofol) or its components, or when general anesthesia or sedation are contraindicated. See package insert for full prescribing information, adverse reactions and precautionary statements.

PropoFlo 28 Safety Information

Indications:

PropoFlo™ 28 is an intravenous anesthetic injection for use in dogs for induction and maintenance of general anesthesia by intermittent bolus injections for short procedures and induction where maintenance is provided by anesthetics.

Important PropoFlo Risk Information

Warnings Precautions, and Contraindications:

Warnings, Precautions, and Contraindications: When using propofol, dogs should be continuously monitored and facilities for the maintenance of a patent airway, artificial ventilation, and oxygen supplementation must be immediately available. PropoFlo™ 28 is contraindicated in dogs with a known hypersensitivity to propofol or its components, or when general anesthesia or sedation are contraindicated. To avoid microbial overgrowth, the contents must be used within 28 days (4 weeks) of the date opened. Failure to follow aseptic handling procedures may result in microbial contamination causing fever, infection/sepsis, and/or other life threatening illness. Do not use if contamination is suspected. Careful monitoring of the patient is necessary when using propofol as a maintenance anesthetic due to the possibility of rapid arousal.

Adverse Reactions:

The primary side effect of propofol is respiratory depression as evidenced by tachypnea and apnea.

Side Effects:

The primary side effect of propofol is respiratory depression as evidenced by tachypnea and apnea.

How Supplied:

PropoFlo™ 28 is supplied in cartons of five-20 mL (200 mg per vial) vials containing 10 mg propofol per mL.